We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Trial for Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00076531
Recruitment Status : Completed
First Posted : January 27, 2004
Last Update Posted : January 28, 2008
Sponsor:
Information provided by:

Study Description
Brief Summary:
Phase III trial using an injectable for treatment of prostate cancer.

Condition or disease Intervention/treatment Phase
Prostate Cancer Drug: Leuprolide Acetate for Injectable Suspension 22.5 mg Phase 3

Study Design

Study Type : Interventional  (Clinical Trial)
Masking: None (Open Label)
Primary Purpose: Treatment
Study Start Date : December 2003
Primary Completion Date : November 2004

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Prostate Cancer
U.S. FDA Resources

Arms and Interventions


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00076531


Sponsors and Collaborators
Oakwood Laboratories, LLC
Investigators
Study Chair: James A. Page, M.D. Oakwood Laboratories, LLC
More Information

Additional Information:
ClinicalTrials.gov Identifier: NCT00076531     History of Changes
Other Study ID Numbers: OL-007
First Posted: January 27, 2004    Key Record Dates
Last Update Posted: January 28, 2008
Last Verified: January 2008

Keywords provided by Oakwood Laboratories, LLC:
Prostate
Cancer
PSA
Leuprolide

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Genital Diseases, Male
Prostatic Diseases
Leuprolide
Fertility Agents, Female
Fertility Agents
Reproductive Control Agents
Physiological Effects of Drugs
Antineoplastic Agents, Hormonal
Antineoplastic Agents